JEAN STALCUP: Open Payments
NPI 1104532811 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 16 payments from 9 companies in 2025. Trend: 2023 $260 · 2024 $96 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $66 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
| UCB, Inc. | 1 | $32 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $27 |
| Organon LLC | 3 | $22 |
| Almirall LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $16 |
Products named: ILUMYA, NEMLUVIO, Bimzelx, Seysara, COSENTYX, Zoryve, Winlevi, SOFDRA.
Industry payments across AL — which companies pay providers there.
